US 11,896,803 B2Granted

Electrocardiogram (ECG) electrodes having bio-potential electrodes

AssigneeMedicus Engineering Aps

InventorJesper Fleischer

Life of this patent

Estimating the term…

Loading patent…

Abstract

Disclosed herein are devices, methods and systems for monitoring and detection of adverse events in a subject. In an embodiment, an insulin delivery device includes an insulin injection device in communication with a controller for controlling the insulin injection device. The controller is configured to receive a heart signal from one or more heart sensors, and a blood glucose signal from one or more blood glucose sensors. The controller is further configured to analyze changes in the heart rhythm of the subject based on the heart signal and determine, based on the changes in the heart rhythm and the blood glucose signal, whether the subject is and/or will be experiencing an adverse event. Upon determination that the subject is or will be experiencing an adverse event, the controller determines one or more parameters of delivery of insulin to be delivered to the subject. Finally, the controller is configured to control the injection device to deliver insulin to the subject in accordance with the determined one or more parameters of delivery.

Claims20

Dependent claims

A device comprising two interchangeable and independent coated electrocardiogram (ECG) electrodes, wherein the ECG electrodes form a part of the housing of a device, wherein each ECG electrode comprises at least a first sub-electrode and a second sub-electrode;

wherein the first sub-electrode and the second sub-electrode are separately addressable;
wherein the first sub-electrode and the second sub-electrode are separated by an insulating portion of the housing which is not coated;
wherein the device is configured to collect ECG data from both hands of a person when each hand is in contact with one of the two independent coated ECG electrodes;
wherein each of the first sub-electrode and the second sub-electrode comprises a coating that is an integral part and present at an exterior of the housing of the device;
wherein the coating functions as interchangeable and disposable ECG electrodes;
wherein the coated ECG electrodes comprises a plurality of layers, wherein at least a layer of the plurality of the layers comprises silver colloidal metal particles, wherein the silver colloidal metal particles are present in a liquid or a gel,
wherein the device has a provision for a tab to connect an external mouthpiece configured to perform a cardioreflex test;
and wherein the device is configured to enable the person to operate the mouthpiece when both the hands of the person are positioned on the two independent coated ECG electrodes.

5 more elements

Dependencies are inferred from the claim text.

Facts

Application: 15/539,137Filed 22 Dec 2015 · us provisional application
Priority: 22 Dec 2014
Published: US 2019/0209776 A111 Jul 2019
Granted: 13 Feb 2024
Term ends: Not estimatedThe source records don’t support an estimate.

Classification14 codes

A61M 5/1723
Electrical or electronic: using feedback of body parameters, e.g. blood sugar or pressure
A61B 5/0531
Measuring electrical impedance or conductance of a portion of the body: measuring skin impedance
A61B 5/087
Measuring devices for evaluating the respiratory organs: measuring breath flow
A61B 5/282
For electrocardiography [ECG]: holders for multiple electrodes